{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T20:45:15Z","timestamp":1789073115239,"version":"build-2803163510"},"reference-count":19,"publisher":"Elsevier BV","issue":"45","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,9,24]],"date-time":"2015-09-24T00:00:00Z","timestamp":1443052800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Kaketsuken"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.vaccine.2015.09.067","type":"journal-article","created":{"date-parts":[[2015,10,21]],"date-time":"2015-10-21T05:25:53Z","timestamp":1445405153000},"page":"6120-6127","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Freeze-dried live attenuated smallpox vaccine prepared in cell culture \u201cLC16-KAKETSUKEN\u201d: Post-marketing surveillance study on safety and efficacy compliant with Good Clinical Practice"],"prefix":"10.1016","volume":"33","author":[{"given":"Yasumasa","family":"Nishiyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Kanatani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiko","family":"Shinmura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Yokote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So","family":"Hashizume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.09.067_bib0100","first-page":"325","article-title":"Internal symposium on smallpox vaccines","volume":"19","author":"Hashizume","year":"1973","journal-title":"Bilthoven Symp Ser Immunobiol Stand"},{"key":"10.1016\/j.vaccine.2015.09.067_bib0105","series-title":"Vaccinia virus as vectors for vaccine antigens.","first-page":"421","article-title":"Properties of attenuated mutant of vaccinia virus, LC16m8, derived from Lister strain","author":"Hashizume","year":"1985"},{"key":"10.1016\/j.vaccine.2015.09.067_bib0110","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0140-6736(03)14674-0","article-title":"Myocarditis: the unexpected return of smallpox vaccine adverse events","volume":"362","author":"Chen","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2015.09.067_bib0115","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1126\/science.304.5672.809a","article-title":"Biodefense. Smallpox vaccines: looking beyond the next generation","volume":"304","author":"Enserink","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2015.09.067_bib0120","doi-asserted-by":"crossref","first-page":"9458","DOI":"10.1073\/pnas.1233578100","article-title":"Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses","volume":"100","author":"Belyakov","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2015.09.067_bib0125","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nature02331","article-title":"Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox","volume":"428","author":"Earl","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2015.09.067_bib0130","first-page":"1","article-title":"Meeting of the Strategic Advisory Group of Experts on immunization, november 2013 \u2013 conclusions and recommendations","volume":"89","author":"WHO.","year":"2014","journal-title":"WHO Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2015.09.067_bib0135","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1093\/infdis\/jiq162","article-title":"Smallpox vaccine safety is dependent on T cells and not B cells","volume":"203","author":"Gordon","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.09.067_bib0140","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1093\/infdis\/jir527","article-title":"Safety and immunogenicity of LC16m8, an attenuated smallpox vaccine in vaccinia-naive adults","volume":"204","author":"Kennedy","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.09.067_bib0145","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.1016\/j.vaccine.2005.03.029","article-title":"Highly attenuated smallpox vaccine protects rabbits and mice against pathogenic orthopoxvirus challenge","volume":"24","author":"Empig","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.09.067_bib0150","doi-asserted-by":"crossref","first-page":"4152","DOI":"10.1073\/pnas.0406671102","article-title":"Genetically stable and fully effective smallpox vaccine strain constructed from highly attenuated vaccinia LC16m8","volume":"102","author":"Kidokoro","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2015.09.067_bib0155","doi-asserted-by":"crossref","first-page":"11873","DOI":"10.1128\/JVI.79.18.11873-11891.2005","article-title":"An attenuated LC16m8 smallpox vaccine: analysis of full-genome sequence and induction of immune protection","volume":"79","author":"Morikawa","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.09.067_bib0160","doi-asserted-by":"crossref","first-page":"5179","DOI":"10.1128\/JVI.02642-05","article-title":"LC16m8, a highly attenuated vaccinia virus vaccine lacking expression of the membrane protein B5R, protects monkeys from monkeypox","volume":"80","author":"Saijo","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.09.067_bib0165","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1001\/jama.2009.289","article-title":"Clinical and immunological response to attenuated tissue-cultured smallpox vaccine LC16m8","volume":"301","author":"Saito","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2015.09.067_bib0170","series-title":"Defense of Japan","first-page":"2005","author":"Agency","year":"2005"},{"key":"10.1016\/j.vaccine.2015.09.067_bib0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2015.07.076","article-title":"Vaccinia virus strain LC16m8 defective in the B5R gene keeps strong protection comparable to its parental strain Lister in immunodeficient mice","author":"Yokote","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.09.067_bib0180","first-page":"269","article-title":"Report of the National Smallpox Vaccination Research Committee: study of side effects, complications and their treatment","volume":"3","author":"Yamaguchi","year":"1975","journal-title":"Clin Virol"},{"key":"10.1016\/j.vaccine.2015.09.067_bib0185","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1128\/CVI.00199-14","article-title":"Safety of attenuated smallpox vaccine LC16m8 in immunodeficient mice","volume":"21","author":"Yokote","year":"2014","journal-title":"Clin Vaccine Immunol"},{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2015.09.067_bib0190","doi-asserted-by":"crossref","first-page":"S258","DOI":"10.1086\/524749","article-title":"Monitoring the safety of a smallpox vaccination program in the United States: report of the joint Smallpox Vaccine Safety Working Group of the advisory committee on immunization practices and the Armed Forces Epidemiological Board","volume":"46","author":"Neff","year":"2008","journal-title":"Clin Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15013432?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15013432?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T14:59:21Z","timestamp":1537282761000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15013432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":19,"journal-issue":{"issue":"45","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0264410X15013432"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.09.067","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Freeze-dried live attenuated smallpox vaccine prepared in cell culture \u201cLC16-KAKETSUKEN\u201d: Post-marketing surveillance study on safety and efficacy compliant with Good Clinical Practice","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.09.067","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}